This inventor holds 1 USPTO granted patent. Top assignee: Novimmune Sa. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Susana Salgado-Pires: Innovator in Therapeutic Antibodies
Introduction
Susana Salgado-Pires is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of immunology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for complex medical conditions.
Latest Patents
Salgado-Pires holds a patent for "Anti-TLR4 antibodies and methods of use thereof." This invention relates to anti-Toll-like Receptor 4 (TLR4) antagonists, including antibodies that specifically bind to TLR-4. The patent outlines methods for using these anti-TLR4 antagonists as therapeutics, particularly for inhibiting or delaying the progression of Graft-versus-Host disease (GvHD). It also addresses improving the survival of GvHD subjects and transplanted biological materials.
Career Highlights
Salgado-Pires is associated with Novimmune SA, a company known for its focus on developing innovative antibody-based therapies. Her work has been instrumental in advancing therapeutic options for patients suffering from GvHD and related conditions.
Collaborations
She collaborates with notable colleagues, including Emmanuel Monnet and Limin Shang, who contribute to her research and development efforts. Their combined expertise enhances the potential impact of their work in the field of immunotherapy.
Conclusion
Susana Salgado-Pires is a trailblazer in the development of anti-TLR4 antibodies, with a focus on improving patient outcomes in GvHD. Her innovative work at Novimmune SA exemplifies the critical role of inventors in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile